MedTrace Logo

Enforced Reduction in Physical Activity and Recovery in Older Adults

NCT04997447 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-08-21

No results posted yet for this study

Summary

Apparently healthy and well-functioning community dwelling 70-80 year-olds will be recruited to the study. All subjects undergo pre-screening for suitability and a physicians examination, as well as 7-day habitual daily steps are measured to ascertain baseline physical activity. Half of the recruited subjects (n=40) will be randomized into the intervention group and half (n=40) randomized into the control group. The intervention group is then required to reduce their daily steps to \<2000 for a 2-week period. Thereafter, the intervention group participates to a 4-week strength+endurance training rehabilitation program and no longer has restricted daily step count. The control group continues their normal habitual physical activity level throughout the 6-week study period.

Conditions

  • Muscle Degeneration
  • Body Weight Changes
  • Walking, Difficulty

Interventions

BEHAVIORAL

Step-reduction/Exercise Rehab

2-week limited daily steps (\<2000), and then 4 weeks of typical strength+endurance exercise for older adults

Sponsors & Collaborators

  • University of Eastern Finland

    collaborator OTHER

  • University of Jyvaskyla

    lead OTHER

Principal Investigators

  • Simon Walker, PhD · University of Jyväskylä, Finland

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-15
Primary Completion
2021-12-22
Completion
2022-11-22

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04997447 on ClinicalTrials.gov